Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Alhemo is a biological agent that your hematologist or oncologist may prescribe for treating the hematologic disorder hemophilia B. Patients with this condition have abnormally low blood clotting, leading to an increased propensity for excessive bleeding. Some symptoms are unexplained bleeding, blood in urine or stool, large or deep bruises, and indicators of serious bleeds.
Alhemo's mechanism of action involves binding to the protein TFPI, which regulates blood clot formation under normal circumstances. By inhibiting TFPI, Alhemo enhances blood clotting, thereby mitigating the risk of excessive bleeding.
Alhemo is available in various prefilled syringes, including 15 mg, 60 mg, 150 mg, and 300 mg.
Your specialist will prescribe a predetermined schedule and dosage for administration. After four weeks of treatment, blood tests are conducted to measure Alhemo levels, allowing for dose adjustments if necessary.
In case of a missed dose, consultation with a healthcare professional is recommended.
The active ingredient in Alhemo is concizumab.
There are only a limited number of drug-drug interactions with this medication, including:
Alhemo use carries the risk of serious blood clots, potentially resulting in permanent damage or mortality. Individuals with a personal or family history of blood clots should inform their doctors.
Watch for signs and symptoms of blood clots is advised during treatment.
Notably, Alhemo is contraindicated in patients below 12 and during pregnancy.
Women taking Alhemo should employ highly effective birth control methods during treatment and for seven weeks after completion.
Common adverse reactions include:
Alhemo [package insert]. Mississauga, Ontario: Novo Nordisk; March 2023.